Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled...

Area of Science:

• Cardiology
• Pharmacology
• Clinical Trials

Background:

• Amlodipine is a common treatment for arterial hypertension and coronary artery disease (CAD).
• Peripheral edema and headache are known side effects that can limit amlodipine use.
• The precise contribution of amlodipine to these side effects requires further clarification.

Purpose of the Study:

• To quantify the incidence of peripheral edema and headache associated with amlodipine.
• To determine the placebo-adjusted rates of these side effects.
• To investigate the dose-response relationship for amlodipine-induced edema and headache.

Main Methods:

• A meta-analysis of randomized, placebo-controlled trials involving amlodipine for hypertension and CAD.
• Inclusion criteria focused on trials reporting edema and headache incidence.
• Placebo-adjusted rates were calculated to differentiate drug-related from unrelated events.

Main Results:

• Edema occurred more frequently with amlodipine (16.6%) compared to placebo (6.2%), with a risk ratio of 2.9.
• The placebo-adjusted rate for edema was 63%, suggesting 37% of cases were unrelated to amlodipine.
• Headache incidence was lower with amlodipine (7.9%) versus placebo (10.9%), a risk ratio of 0.77.
• Lower amlodipine doses (2.5-5 mg) were associated with reduced edema and headache compared to high doses (10 mg).

Conclusions:

• While amlodipine significantly increases the risk of peripheral edema, a substantial portion of these events may be unrelated to the drug.
• Headache incidence is decreased with amlodipine treatment, particularly at low to medium dosages.
• Dose selection is crucial for managing amlodipine's side effect profile, especially concerning edema and headache.